NCT03706222View on ClinicalTrials.gov

Drug-Drug Interactions of Grazoprevir/Elbasvir in Taiwan

CompletedOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

October 22, 2018

Primary Completion Date

February 25, 2019

Study Completion Date

February 25, 2019

Conditions
Drug Interaction Potentiation
Interventions
DRUG

elbasvir/grazoprevir

Comedications during elbasvir/grazoprevir will be recorded and analyzed for potential drug-drug interaction.

Trial Locations (1)

704

National Cheng Kung University Hospital, Tainan City

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

National Cheng-Kung University Hospital

OTHER

NCT03706222 - Drug-Drug Interactions of Grazoprevir/Elbasvir in Taiwan | Biotech Hunter | Biotech Hunter